Publications by authors named "Jo Jones"

Claim this Profile
E
Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1- C]pyruvate MRI.
Ines Horvat-Menih, Mary A McLean, Jonathan Birchall, Maria Jesus Zamora Morales, Marta Wylot, James O Jones

Abdom Radiol (NY)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Case of the Month' from Addenbrooke's Hospital, Cambridge, UK: surgery after near complete response to combined immunotherapy and tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma with inferior vena cava tumour thrombus.
James P Blackmur, James N Armitage, James O Jones, Antony C P Riddick, Thomas J Mitchell

BJU Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is required to deliver practice-changing neoadjuvant trials in kidney cancer? An International Neoadjuvant Kidney Cancer Consortium Delphi study.
S H Rossi, T K Choueiri, M Jewett, J O Jones, A Laird

Ann Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer Consortium.
James P Blackmur, J C Koen van der Mijn, Anne Y Warren, Lisa Browning, Femke Burgers, James O Jones

Lancet Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Activity Relationship of Antischistosomal Aryl Hydantoin (AR102).
Derek A Leas, Cécile Häberli, Karen L White, David M Shackleford, Jeremy O Jones

J Med Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cambridge kidney One-Stop Mass Investigation Clinic (CkOSMIC): A Nonrandomised Feasibility Study.
Chiara Re, James P Blackmur, Teele Kuusk, Thomas J Mitchell, James N Armitage, James O Jones

Eur Urol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a Novel Indolizine RORγT Inverse Agonist Using the AI-Driven Drug Design Platform.
Rafał A Bachorz, Joanna Pastwińska, Michael S Lawless, David W Miller, Anna Sałkowska, Jeremy O Jones

ACS Med Chem Lett· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiogenic and immune predictors of neoadjuvant axitinib response in renal cell carcinoma with venous tumour thrombus.
Rebecca Wray, Hania Paverd, Ines Machado, Johanna Barbieri, Farhana Easita, James O Jones

Nat Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoaminergic neurotransmitters are bimodal effectors of tau aggregation.
Xinmin Chang, Amanda M Tse, Marina Fayzullina, Angela Albanese, Minchan Kim, Jeremy O Jones

Sci Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Dose Drug Development Candidate for Schistosomiasis.
Derek A Leas, Jennifer Keiser, Susan A Charman, David M Shackleford, Jeremy O Jones

ACS Infect Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiarm, non-randomised, single-centre feasibility study-investigation of the differential biology between benign and malignant renal masses using advanced magnetic resonance imaging techniques (IBM-Renal): protocol.
Ines Horvat-Menih, Mary A McLean, Maria Jesus Zamora-Morales, Marta Wylot, Joshua Kaggie, James O Jones

BMJ Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-resolution and highly accelerated MRI T2 mapping as a tool to characterise renal tumour subtypes and grades.
Ines Horvat-Menih, Hao Li, Andrew N Priest, Shaohang Li, Andrew B Gill, James O Jones

Eur Radiol Exp· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Germline Variants Associated with Toxicity to Immune Checkpoint Blockade.
James O Jones, Thomas J Mitchell, Grant D Stewart

Eur Urol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lithographically defined encoded magnetic heterostructures for the targeted screening of kidney cancer.
Selma Leulmi Pichot, Tarun Vemulkar, Jeroen Verheyen, Lauren Wallis, James O Jones

Nanoscale Adv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA).
Grant D Stewart, Sarah J Welsh, Stephan Ursprung, Ferdia A Gallagher, James O Jones, Robert J Jones

Br J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A purine metabolic checkpoint that prevents autoimmunity and autoinflammation.
Svetlana Saveljeva, Gavin W Sewell, Katharina Ramshorn, M Zaeem Cader, James A West, James O Jones

Cell Metab· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microenvironmental modulation of the developing tumour: an immune-stromal dialogue.
James O Jones, William M Moody, Jacqueline D Shields

Mol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virtual screening and biological evaluation of PPARγ antagonists as potential anti-prostate cancer agents.
Suliman Almahmoud, Catherine C Elix, Jeremy O Jones, Corey R Hopkins, Jonathan L Vennerstrom

Bioorg Med Chem· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide.
Naomi B Haas, Michael J LaRiviere, Thomas H Buckingham, Yauheniya Cherkas, Karl Calara-Nielsen, Jeremy O Jones

Prostate Cancer Prostatic Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA analysis of metastatic renal cell carcinoma.
Jingbo Zhang, Yunchao Liu, Bing Xu, Fuwei Li, Yan Wang, Jeremy O Jones

Mol Clin Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromal-driven and Amyloid β-dependent induction of neutrophil extracellular traps modulates tumor growth.
Hafsa Munir, James O Jones, Tobias Janowitz, Markus Hoffmann, Maximilien Euler

Nat Commun· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.
Derek C Angus, Lennie Derde, Farah Al-Beidh, Djillali Annane, Yaseen Arabi, Jo Jones, Andrea Jones

JAMA· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastroesophageal cancer: Navigating the immune and genetic terrain to improve clinical outcomes.
James O Jones, Elizabeth C Smyth

Cancer Treat Rev· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms.
Catherine C Elix, Meghan M Salgia, Maya Otto-Duessel, Ben T Copeland, Christopher Yoo, Jeremy O Jones

Prostate· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic, Health Care, and Fertility-related Characteristics of Adults Aged 18-44 Who Have Ever Been in Foster Care: United States, 2011-2017.
Colleen N Nugent, Chinagozi Ugwu, Jo Jones, Sharon Newburg-Rinn, Tammy White

Natl Health Stat Report· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis